Shawn Hassler

Statistics

Publications

Citations

462

H-Index

Active since

2015

Affiliations

Gilead Sciences (United States)(Current)

Yale University

Ruane Medical

University of Alabama at Birmingham

Shawn Hassler is an author at Gilead Sciences (United States) specializing in clinical pharmacology, public health, and pre-exposure prophylaxis comparison.

Publications per year

2015–2024

Publications

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

Colleen F. Kelley, Maribel Acevedo-Quiñones, Allison L. Agwu et al. · New England Journal of Medicine · 2024 · 229 citations

Public Health, Pharmacology, Pharmacotherapy +17

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial

Edgar T. Overton, Jack T. Stapleton, Ian Frank et al. · Open Forum Infectious Diseases · 2015 · 142 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer et al. · The Lancet HIV · 2021 · 91 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

1–3 of 3